Miraca Life Sciences has discontinued offering the EoGenius gene expression assay for diagnosis of eosinophilic esophagitis.
Clinicians with questions should contact their Miraca sales representative or our Client Services team.
Learn more about Miraca's Anatomic Pathology services
“The Point of Diagnosis Patient Advocacy (PDPA) program saves us time explaining to the patient the information Miraca now provides.” Doug Wright, MD
© 2017 Miraca Life Sciences, Inc. All rights reserved.
Trademarks are the property of their respective owners.
6655 N MacArthur BlvdIrving, TX 75039